Home - National Cancer Centre Singapore

slide-1
slide-2

Let Us Help

Simply tell us who you are and what you want to do below.

I’m a

Patient

Patient
Healthcare Professional
Caregiver
Job Seeker

looking

Pharmacy Services

Here are 2 easy ways to save time. Click here to find out how.

Clinical Trials at NCCS

Find out if you’re eligible for a clinical trial by speaking to your treating oncologist!

In Good Health

Read our newsletter for patient stories, health tips and the latest in cancer care!

Our Commitment to Our Patients

Patients

Discover information relevant to individuals seeking treatment.
Healthcare Professionals

Learn how medical practitioners are equipped with relevant knowledge and skills to deliver quality care.
Community Partners

Learn how NCCS brings medical care in community.

Our Specialties and Services

Goh Cheng Liang Proton Therapy Centre

We give patients in Singapore and the region, access to proton beam therapy, an advanced radiation treatment that precisely targets and destroys cancer cells, while minimising damage to surrounding healthy tissues.

Care & Support

Learn more about coping with side effects, as well as cancer recovery. Caregivers can also find information on caring for their loved ones with cancer here.

Treatments at NCCS

Learn more about the types of treatments available at NCCS.

What to expect during your clinic visit

Find out more about our resources that are useful for patients and caregivers during the cancer treatment journey.

Recently Searched Cancer Types

Click a tag for more information on the cancer type

Breast Cancer Colorectal Cancer Liver Cancer Lung Cancer Prostate Cancer

Looking for other cancer types?

Click here

In The News

Research 本地人口健康研究完成收集10万人基因数据研究即将进入新阶段本地大规模人口健康研究SG100K已完成收集10万人健康与基因信息的工作，并且进入了基因组测序和分析阶段.

09 Nov 2025 | Lianhe Zaobao Read Story

Patient Care 本地成立全球综合医疗保健中心和全球药剂中心推进跨专业国际合作新加坡保健服务集团和杜克－新加坡国立大学医学院，联合成立全球综合医疗保健中心和全球药剂中心，将建立全球数据库，推进跨专业国际合作以及领导级人才培养.

07 Nov 2025 | Lianhe Zaobao Read Story

Research New therapy shows promise in treating advanced HER2 mutated lung cancer A global, multicentre, phase 1/2 clinical trial that included clinician-scientists and researchers from MD Anderson Cancer Centre, Seoul National University and the National Cancer Centre Singapore has indicated positive results in treating advanced HER2-mutant non-small-cell lung cancer (NSCLC) with sevabertinib, an oral HER2-targeted tyrosine kinase inhibitor.

21 Oct 2025 Read Story

Patient Care TTSH to train TCM students from NTU on patient, integrative care From 2027, junior doctors shadowing senior physicians on their rounds at Tan Tock Seng Hospital (TTSH) will be joined by undergraduates studying traditional Chinese medicine (TCM).

10 Oct 2025 | The Straits Times Read Story

View All

Upcoming Events

View All Events